Skip to main content
. 2021 Nov 22;2021(11):CD004407. doi: 10.1002/14651858.CD004407.pub5

Comparison 19. Safety: demyelinating diseases ‐ multiple sclerosis ‐ acute disseminated encephalomyelitis.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
19.1 Case‐control 2   Odds Ratio (IV, Fixed, 95% CI) Subtotals only
19.1.1 Multiple sclerosis 1   Odds Ratio (IV, Fixed, 95% CI) 1.13 [0.62, 2.05]
19.1.2 Acute disseminated encephalomyelitis 1   Odds Ratio (IV, Fixed, 95% CI) 1.03 [0.44, 2.42]